Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis

McKerrell, Thomas, Park, Naomi, Moreno, Thaidy, Grove, Carolyn S., Ponstingl, Hannes, Stephens, Jonathan, Crawley, Charles, Craig, Jenny +10 more·2015·Cell Reports

Cited by (534)

Items 201–300 of 534

  1. A targeted amplicon sequencing panel to simultaneously identify mosquito species and Plasmodium presence across the entire Anopheles genus
    Alex Makunin, Petra Korlević, Naomi Park, Scott Goodwin, Robert Michael Waterhouse, Katharina von Wyschetzki, Christopher G. Jacob, Robert M. Davies, Dominic P. Kwiatkowski, Brandyce St. Laurent et al. · 2021 · Molecular Ecology Resources
  2. Concordance for clonal hematopoiesis is limited in elderly twins
    Margarete A. Fabre, Thomas McKerrell, Maximilian Zwiebel, M. S. Vijayabaskar, Naomi Park, Philippa M. Wells, Roland Rad, Panos Deloukas, Kerrin S. Small, Claire J. Steves et al. · 2019 · Blood
  3. Large-scale Identification of Clonal Hematopoiesis and Mutations Recurrent in Blood Cancers
    Julie Ellen Feusier, Sasi Arunachalam, Tsewang Tashi, Monika J. Baker, Chad Hilton Vansant-Webb, Amber Ferdig, Bryan E. Welm, Juan L. Rodríguez-Flores, Christopher Ours, Lynn B. Jorde et al. · 2021 · Blood Cancer Discovery
  4. Effect of lenalidomide treatment on clonal architecture of myelodysplastic syndromes without 5q deletion
    Virginie Chesnais, Aline Renneville, Andrea Toma, Jérôme Lambert, Marie Passet, Florent Dumont, Sylvie Chevret, Julie Lejeune, Anna Raimbault, Aspasia Stamatoullas et al. · 2015 · Blood
  5. Clonal Hematopoiesis, Inflammation, and Hematologic Malignancy
    Rashmi Kanagal‐Shamanna, David B. Beck, Katherine R. Calvo · 2023 · Annual Review of Pathology Mechanisms of Disease
  6. Clonal hematopoiesis: Molecular and clinical implications
    Yael N. Kusne, Zhuoer Xie, Mrinal M. Patnaik · 2022 · Leukemia Research
  7. Lymphoid clonal hematopoiesis: implications for malignancy, immunity, and treatment
    Kelly von Beck, Troy Alexander von Beck, Paul Brent Ferrell, Alexander G. Bick, Ashwin Kishtagari · 2023 · Blood Cancer Journal
  8. Next Generation Sequencing in MPNs. Lessons from the Past and Prospects for Use as Predictors of Prognosis and Treatment Responses
    Vibe Skov · 2020 · Cancers
  9. Hematopoietic Stem Cells and Their Niche in Bone Marrow
    Munju Kwon, Byoung Soo Kim, Sik Yoon, Sae‐Ock Oh, Dongjun Lee · 2024 · International Journal of Molecular Sciences
  10. Alternative splicing in aging and age-related diseases
    Huan Li, Ziyue Wang, Tianyi Ma, Gang Wei, Ting Ni · 2017 · Translational Medicine of Aging
  11. Recent insights regarding the molecular basis of myeloproliferative neoplasms
    Mi‐Ae Jang, Chul Won Choi · 2019 · The Korean Journal of Internal Medicine
  12. Stem Cell DNA Damage and Genome Mutation in the Context of Aging and Cancer Initiation
    Lara Al Zouabi, Allison J. Bardin · 2020 · Cold Spring Harbor Perspectives in Biology
  13. The Dynamic Interface Between the Bone Marrow Vascular Niche and Hematopoietic Stem Cells in Myeloid Malignancy
    Laura Mosteo, Joanna A Storer, Kiran Batta, Emma J Searle, Delfim Duarte, Daniel H. Wiseman · 2021 · Frontiers in Cell and Developmental Biology
  14. JAK2V617F mutation is highly prevalent in patients with ischemic stroke: a case-control study
    Marie Hvelplund Kristiansen, Lasse Kjær, Vibe Skov, Morten Kranker Larsen, Christina Ellervik, Hans Carl Hasselbalch, Troels Wienecke · 2023 · Blood Advances
  15. Different niches for stem cells carrying the same oncogenic driver affect pathogenesis and therapy response in myeloproliferative neoplasms
    Élodie Grockowiak, Claudia Korn, Justyna M. Rak, Veronika Lysenko, Adrien Hallou, Francesca M. Panvini, Matthew Williams, Claire Fielding, Zijian Fang, Eman Khatib-Massalha et al. · 2023 · Nature Cancer
  16. The ageing genome, clonal mosaicism and chronic disease
    Mitchell J. Machiela, Stephen Jacob Chanock · 2017 · Current Opinion in Genetics & Development
  17. From clonal hematopoiesis to myeloid leukemia and what happens in between: Will improved understanding lead to new therapeutic and preventive opportunities?
    Jan Philipp Bewersdorf, Anastasia Ardasheva, Nikolai Alexandrovich Podoltsev, Abhay Singh, Giulia Biancon, Stephanie Halene, Amer Methqal Zeidan · 2019 · Blood Reviews
  18. Clinical implementation and current advancement of blood liquid biopsy in cancer
    Kazunori Watanabe, Yusuke Nakamura, Siew‐Kee Low · 2021 · Journal of Human Genetics
  19. Genomic and functional integrity of the hematopoietic system requires tolerance of oxidative DNA lesions
    Ana Martín-Pardillos, Anastasia Tsaalbi‐Shtylik, Si Chen, Seka Lazare, Ronald P. van Os, Albertina Dethmers-Ausema, Nima Borhan Fakouri, Matthias Bosshard, Rossana Aprigliano, Barbara van Loon et al. · 2017 · Blood
  20. Emerging therapies for acute myeloid leukemia: translating biology into the clinic
    Simon Kavanagh, Tracy Murphy, Arjun Law, Dana Yehudai, Jenny Ho, Steve Chan, Aaron David Schimmer · 2017 · JCI Insight
  21. Quantitative Single-Cell Proteomics as a Tool to Characterize Cellular Hierarchies
    Erwin M. Schoof, Benjamin Furtwängler, Nil Üresin, Nicolas Rapin, Simonas Savickas, Coline Gentil, Eric R. Lechman, Ulrich auf dem Keller, John Edgar Dick, Bo Torben Porse · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  22. Stem cell donors should not be screened for clonal hematopoiesis
    Christopher James Gibson, Robert Coleman Lindsley · 2020 · Blood Advances
  23. Predicting cytopenias, progression, and survival in patients with clonal cytopenia of undetermined significance: a prospective cohort study
    Catherine A. Cargo, Elsa Bernard, Tumas Beinortas, Kelly L. Bolton, Paul Glover, Helen Warren, Daniel Payne, Rukhsaar Ali, Alesia Abigael Khan, Mike Short et al. · 2023 · The Lancet Haematology
  24. How do messenger RNA splicing alterations drive myelodysplasia?
    Poorval M. Joshi, Stephanie Halene, Omar Ibrahim Abdel-Wahab · 2017 · Blood
  25. Single-cell approaches identify the molecular network driving malignant hematopoietic stem cell self-renewal
    Mairi S. Shepherd, Juan Li, Nicola K. Wilson, Caroline A. Oedekoven, Jiangbing Li, Miriam Belmonte, Juergen Fink, Janine C. M. Prick, Dean C. Pask, Tina L. Hamilton et al. · 2018 · Blood
  26. Aging, clonal hematopoiesis and preleukemia: not just bad luck?
    Liran I. Shlush, Sasan Zandi, Shalev Itzkovitz, Andre C. Schuh · 2015 · International Journal of Hematology
  27. ASXL1 mutations in AML are associated with specific clinical and cytogenetic characteristics
    Katerina Kakosaiou, Fotios P. Panitsas, Aggeliki Daraki, Maria N. Pagoni, Paraskevi Apostolou, Agapi Ioannidou, Ioanna Vlachadami, Theodoros P. Marinakis, Chara Giatra, Diamantina Vasilatou et al. · 2018 · Leukemia & lymphoma/Leukemia and lymphoma
  28. Molecular landscapes of human hematopoietic stem cells in health and leukemia
    Aditi Vedi, Antonella Santoro, Cyrille F. Dunant, John Edgar Dick, Elisa Laurenti · 2015 · Annals of the New York Academy of Sciences
  29. Telomere attrition becomes an instrument for clonal selection in aging hematopoiesis and leukemogenesis
    Matthew A. McLoughlin, Sruthi Cheloor Kovilakam, William G. Dunn, Muxin Gu, Jake Tobin, Yash Pershad, Nicholas Williams, Daniel A. Leongamornlert, Kevin J. Dawson, Laura Bond et al. · 2025 · Nature Genetics
  30. Fate of Hematopoiesis During Aging. What Do We Really Know, and What are its Implications?
    Hal E. Broxmeyer, Yan Liu, Reuben Kapur, Christie M. Orschell, Arafat Aljoufi, James P. Ropa, Thao Le Phuong Trinh, Sarah S. Burns, Maegan L. Capitano · 2020 · Stem Cell Reviews and Reports
  31. Inferring the initiation and development of myeloproliferative neoplasms
    Gurvan Hermange, Alicia Rakotonirainy, Mahmoud Bentriou, Amandine Tisserand, Mira El-Khoury, François Girodon, Christophe Marzac, William Vainchenker, Isabelle Plo, Paul-Henry Cournède · 2022 · Proceedings of the National Academy of Sciences
  32. Stochastic modeling reveals an evolutionary mechanism underlying elevated rates of childhood leukemia
    Andrii I. Rozhok, Jennifer L. Salstrom, James V. DeGregori · 2016 · Proceedings of the National Academy of Sciences
  33. Hematopoietic-specific heterozygous loss of Dnmt3a exacerbates colitis-associated colon cancer
    Yang Feng, Qingchen Yuan, Rachel C. Newsome, Troy M. Robinson, Robert L. Bowman, Ashley N. Zuniga, Kendra N. Hall, Cassandra M. Bernsten, Daniil E. Shabashvili, Kathryn I. Krajcik et al. · 2023 · The Journal of Experimental Medicine
  34. The lifelong natural history of clonal hematopoiesis and its links to myeloid neoplasia
    Margarete A. Fabre, George S. Vassiliou · 2023 · Blood
  35. DNMT3A-coordinated splicing governs the stem state switch towards differentiation in embryonic and haematopoietic stem cells
    Raghav Ramabadran, Jarey H. Wang, Jaime M. Reyes, Anna G. Guzman, Sinjini Gupta, Carina Rosas, Lorenzo Brunetti, Michael C. Gundry, Ayala Tovy, Hali Long et al. · 2023 · Nature Cell Biology
  36. Clonal Hematopoiesis and Mutations of Myeloproliferative Neoplasms
    Lasse Kjær · 2020 · Cancers
  37. Signaling Pathways Regulating Hematopoietic Stem Cell and Progenitor Aging
    Abhishek Kumar Singh, Mark Jordan Althoff, José A. Cancelas · 2018 · Current Stem Cell Reports
  38. Recent advances in the understanding of myelodysplastic syndromes with ring sideroblasts
    Luca Malcovati, Mario Cazzola · 2016 · British Journal of Haematology
  39. Epigenetic Erosion in Adult Stem Cells: Drivers and Passengers of Aging
    Christian Kosan, Florian Heinrich Heidel, Maren Godmann, Holger Bierhoff · 2018 · Cells
  40. Clonal haematopoiesis of indeterminate potential: intersections between inflammation, vascular disease and heart failure
    Leanne Mooney, Carl S. Goodyear, Tamir Chandra, Kristina Kirschner, Mhairi Copland, Mark Colquhoun Petrie, Ninian N. Lang · 2021 · Clinical Science
  41. Telomere length is an independent prognostic marker in MDS but not in de novo AML
    Jenna Williams, Nicole H. Heppel, Bethan Britt‐Compton, Julia W. Grimstead, Rhiannon E. Jones, Sudhir Tauro, David Bowen, Steven Knapper, Michael Groves, Robert Kerrin Hills et al. · 2017 · British Journal of Haematology
  42. Germline mutations in candidate predisposition genes in individuals with cutaneous melanoma and at least two independent additional primary cancers
    Antonia L. Pritchard, Peter A. Johansson, Vaishnavi Nathan, Madeleine Howlie, Judith Symmons, Jane M. Palmer, Nicholas K. Hayward · 2018 · PLoS ONE
  43. Co-mutation landscape and its prognostic impact on newly diagnosed adult patients with NPM1-mutated de novo acute myeloid leukemia
    Yiyi Yao, Yile Zhou, Nanfang Zhuo, Wanzhuo Xie, Haitao Meng, Yinjun Lou, Liping Mao, Hongyan Tong, Jiejing Qian, Min Suk Yang et al. · 2024 · Blood Cancer Journal
  44. Description of a knock-in mouse model of JAK2V617F MPN emerging from a minority of mutated hematopoietic stem cells
    Olivier Mansier, Badr Kilani, Amélie Valérie Guitart, Alexandre Guy, Virginie Gourdou‐Latyszenok, Caroline Marty, Marie Parrens, Isabelle Plo, William Vainchenker, Chloé James · 2019 · Blood
  45. Isocitrate Dehydrogenase Mutations in Myelodysplastic Syndromes and in Acute Myeloid Leukemias
    Ugo Testa, Germana Castelli, Elvira Pelosi · 2020 · Cancers
  46. Cohesin mutations in myeloid malignancies made simple
    Aaron D. Viny, Ross L. Levine · 2017 · Current Opinion in Hematology
  47. Role of Minimal (Measurable) Residual Disease Assessment in Older Patients with Acute Myeloid Leukemia
    Francesco Buccisano, Richard James Dillon, Sylvie D. Freeman, Adriano Venditti · 2018 · Cancers
  48. Genetics of Myeloproliferative Neoplasms
    Jakub Szybinski, Sara C. Meyer · 2021 · Hematology/Oncology Clinics of North America
  49. Clinical implications of SRSF2 mutations in AML patients undergoing allogeneic stem cell transplantation
    Juliane Grimm, Madlen Jentzsch, Marius Bill, Donata Backhaus, Dominic Brauer, Johannes Küpper, Julia C. Schulz, Georg‐Nikolaus Franke, Vladan Vučinić, Dietger W. Niederwieser et al. · 2021 · American Journal of Hematology
  50. Updates in molecular genetics of acute myeloid leukemia
    Jason H. Kurzer, Olga K. Weinberg · 2023 · Seminars in Diagnostic Pathology
  51. Inherited polygenic effects on common hematological traits influence clonal selection on JAK2V617F and the development of myeloproliferative neoplasms
    Jing Guo, Klaudia Walter, Pedro M. Quirós, Muxin Gu, E. Joanna Baxter, John Danesh, Emanuele Di Angelantonio, David J. Roberts, Paola Guglielmelli, Claire N. Harrison et al. · 2024 · Nature Genetics
  52. Evolutionary trajectory of leukemic clones and its clinical implications
    Amos Tuval, Liran I. Shlush · 2019 · Haematologica
  53. Clonal Hematopoiesis of Indeterminate Potential: A Multidisciplinary Challenge in Personalized Hematology
    Gregor Hoermann, Georg Greiner, Andrea Griesmacher, Peter Valent · 2020 · Journal of Personalized Medicine
  54. Aberrant EVI1 splicing contributes to EVI1-rearranged leukemia
    Atsushi Tanaka, Taizo A. Nakano, Masaki Nomura, Hiromi Yamazaki, Jan Philipp Bewersdorf, Roger Mulet‐Lazaro, Simon J. Hogg, Bo Liu, Alex Penson, Akihiko Yokoyama et al. · 2022 · Blood
  55. Convergent somatic evolution commences in utero in a germline ribosomopathy
    Heather E. Machado, Nina Friesgaard Øbro, Nicholas Williams, Shengjiang Tan, Ahmed Z. Boukerrou, Megan Davies, Miriam Belmonte, Emily Mitchell, E. Joanna Baxter, Nicole Mende et al. · 2023 · Nature Communications
  56. AML evolution from preleukemia to leukemia and relapse
    Liran I. Shlush, Amanda Mitchell · 2015 · Best Practice & Research Clinical Haematology
  57. The prognostic implication of SRSF2 mutations in Chinese patients with acute myeloid leukemia
    Jing Chun Yang, Dong‐ming Yao, Ji‐chun Ma, Lei Yang, Hong Yan Guo, Xiang‐mei Wen, Gao-fei Xiao, Zhen Yu Qian, Jiang Lin, Jun Qian · 2016 · Tumor Biology
  58. Post-transcriptional regulation in hematopoiesis: RNA binding proteins take control
    Laura P. M. H. de Rooij, Derek C.H. Chan, Ava Keyvani Chahi, Kristin J. Hope · 2018 · Biochemistry and Cell Biology
  59. Clonal hematopoiesis driven by somatic mutations: A new player in atherosclerotic cardiovascular disease
    Marta Amorós-Pérez, José J. Fuster · 2020 · Atherosclerosis
  60. PU.1-Dependent Enhancer Inhibition Separates <i>Tet2</i> -Deficient Hematopoiesis from Malignant Transformation
    Aivalioti, Maria M., Bartholdy, Boris A., Pradhan, Kith, Bhagat, Tushar D., Zintiridou, Aliona, Jeong, Jong Jin, Thiruthuvanathan, Victor J., Pujato, Mario, Paranjpe, Aditi, Zhang, Chi et al. · 2022 · Blood Cancer Discovery
  61. CHIPing away the progression potential of CHIP: A new reality in the making
    Zhuoer Xie, Amer Methqal Zeidan · 2022 · Blood Reviews
  62. Age-Related Alternative Splicing: Driver or Passenger in the Aging Process?
    Marco Baralle, Maurizio Romano · 2023 · Cells
  63. Genomic instability and genetic heterogeneity in aging: insights from clonal hematopoiesis (CHIP), monoclonal gammopathy (MGUS), and monoclonal B-cell lymphocytosis (MBL)
    Attila Kállai, Zoltan I. Ungvari, Mónika Fekete, Andrea Britta Maier, Gábor Mikala, Hajnalka Andrikovics, Andrea Lehoczki · 2024 · GeroScience
  64. Molecular features of early onset adult myelodysplastic syndrome
    Cassandra M. Hirsch, Bartlomiej P. Przychodzen, Tomas Radivoyevitch, Bhumika J. Patel, Swapna Thota, Michael J. Clemente, Yasunobu Nagata, Thomas LaFramboise, Hetty E. Carraway, Aziz Nazha et al. · 2017 · Haematologica
  65. Acute myeloid leukaemia
    Matthew L. Smith, Thomas McKerrell · 2016 · Wiley eBooks
  66. Association of clonal hematopoiesis and mosaic chromosomal alterations with solid malignancy incidence and mortality
    Pinkal M. Desai, Ying Zhou, Justin E. Grenet, Samuel K. Handelman, Cynthia Crispino, Laura N. Tarbay, Eric A. Whitsel, Gail J. Roboz, Ana Barac, Michael C. Honigberg et al. · 2024 · Cancer
  67. Aging and Bone Metabolism
    Robert J. Pignolo · 2023 · Comprehensive physiology
  68. Molecular Testing in Myelodysplastic Syndromes for the Practicing Oncologist: Will the Progress Fulfill the Promise?
    Aziz Nazha, Mikkael Aaron Sekeres, Steven D. Gore, Amer Methqal Zeidan · 2015 · The Oncologist
  69. Genomic heterogeneity in myeloproliferative neoplasms and applications to clinical practice
    Joe Lee, Anna L. Godfrey, Jyoti Nangalia · 2020 · Blood Reviews
  70. Mutational landscape of blast phase myeloproliferative neoplasms (MPN-BP) and antecedent MPN
    Sergiu Paşca, Helen T. Chifotides, Srđan Verstovšek, Prithviraj Bose · 2022 · International review of cytology
  71. Decoy fitness peaks, tumor suppression, and aging
    Kelly C. Higa, James V. DeGregori · 2019 · Aging Cell
  72. The NOTCH-RIPK4-IRF6-ELOVL4 Axis Suppresses Squamous Cell Carcinoma
    Yue Yan, Marc-Andre Gauthier, Ahmad Malik, Iosifina Fotiadou, Michael Ostrovski, Dzana Dervovic, Logine Ghadban, Ricky Tsai, Gerald D. Gish, Sampath Kumar Loganathan et al. · 2023 · Cancers
  73. Causes of Clonal Hematopoiesis: a Review
    LiJin Joo, Catherine C. Bradley, Steven Hsesheng Lin, Paul A. Scheet, Kevin Thomas Nead · 2023 · Current Oncology Reports
  74. SRSF2-P95H decreases JAK/STAT signaling in hematopoietic cells and delays myelofibrosis development in mice
    Christophe Willekens, Lucie Laplane, Tracy Dagher, Camélia Benlabiod, Nicolas Papadopoulos, Catherine Lacout, Philippe Rameau, Cyril Catelain, Alexia Alfaro, Valérie Edmond et al. · 2023 · Leukemia
  75. Beyond the Edge of Hypomethylating Agents: Novel Combination Strategies for Older Adults with Advanced MDS and AML
    Anne Sophie Kubasch, Uwe Platzbecker · 2018 · Cancers
  76. Concomitant and noncanonical JAK2 and MPL mutations in JAK2V617F‐ and MPLW515 L‐positive myelofibrosis
    Susann Schulze, Rayk Stengel, Nadja Jaekel, Song‐Yau Wang, Georg‐Nikolaus Franke, Martin Roskos, Melanie Schneider, Dietger W. Niederwieser, Haifa Kathrin Al‐Ali · 2019 · Genes Chromosomes and Cancer
  77. DNMT3A mutations are over-represented in young adults with NPM1 mutated AML and prompt a distinct co-mutational pattern
    Luca Vincenzo Cappelli, Manja Meggendorfer, Frank Dicker, Sabine Jeromin, Stephan Hütter, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach, Alexander Höllein · 2019 · Leukemia
  78. Myeloid somatic mutation panel testing in myeloproliferative neoplasms
    David M. Ross, Candice Thomson, Nada Hamad, Steven Lane, Kate Manos, Andrew Grigg, Belinda B. Guo, Wendy N. Erber, Ashleigh P. Scott, Nicholas Viiala et al. · 2021 · Pathology
  79. Myelodysplasia Syndrome, Clonal Hematopoiesis and Cardiovascular Disease
    Camilla Bertuzzo Veiga, Erin Lawrence, Andrew James Murphy, Marco J. Herold, Dragana Dragoljevic · 2021 · Cancers
  80. Clonal Hematopoiesis: Connecting Aging and Inflammation in Atherosclerosis
    Ariel Héctor Polizio, Eunbee Park, Kenneth Walsh · 2023 · Current Atherosclerosis Reports
  81. Clonal haematopoiesis is not prevalent in survivors of childhood cancer
    Grace Collord, Naomi Park, Marina Podestà, Monica Dagnino, Daniela Cilloni, David Jones, Ignacio Varela, Francesco Frassoni, George S. Vassiliou · 2017 · British Journal of Haematology
  82. Aging and Bone Metabolism
    Robert J. Pignolo · 2023 · Comprehensive physiology
  83. Mechanisms underlying the heterogeneity of myelodysplastic syndromes
    Charles Dussiau, Michaëla Fontenay · 2017 · Experimental Hematology
  84. Identification of Biochemical and Molecular Markers of Early Aging in Childhood Cancer Survivors
    Silvia Ravera, Tiziana Vigliarolo, Silvia Bruno, Fabio Morandi, Danilo Marimpietri, Federica Sabatini, Monica Dagnino, Andrea Petretto, Martina Bartolucci, Monica Muraca et al. · 2021 · Cancers
  85. Early detection and intervention of clonal hematopoiesis for preventing hematological malignancies
    Baixin Ye, Yuping Sheng, Mingming Zhang, Yongxian Hu, He Huang · 2022 · Cancer Letters
  86. PARP inhibitors in acute myeloid leukaemia therapy: How a synthetic lethality approach can be a valid therapeutic alternative
    Grigore Gafencu, Ciprian Tomuleasa, Gabriel Ghiaur · 2017 · Medical Hypotheses
  87. Molecular Pathogenesis of Myeloproliferative Neoplasms: Influence of Age and Gender
    Jeffrey Patterson-Fortin, Alison R. Moliterno · 2017 · Current Hematologic Malignancy Reports
  88. The use of genetic tests to diagnose and manage patients with myeloproliferative and myeloproliferative/myelodysplastic neoplasms, and related disorders
    Nicholas C.P. Cross, Anna L. Godfrey, Catherine A. Cargo, Mamta Krishnan Garg, Adam J. Mead, A British Society for Haematology Good Practice Paper · 2021 · British Journal of Haematology
  89. Ageing and cancer: a research gap to fill
    Éric Solary, Nancy Abou‐Zeid, Fabien M. Calvo · 2022 · Molecular Oncology
  90. The Impact of the Cellular Origin in Acute Myeloid Leukemia: Learning From Mouse Models
    J. N. Fisher, N. Kalleda, V. Stavropoulou, J. Schwaller · 2019 · HemaSphere
  91. ICUS/CCUS/CHIP: basics & beyond
    Mili Jain, Anil Kumar Tripathi · 2017 · Expert Review of Hematology
  92. Natural history of clonal haematopoiesis seen in real‐world haematology settings
    Shyam Ajay Patel, William K Gerber, Rena Zheng, Shrinkhala Khanna, Lloyd Hutchinson, Gregory Alan Abel, Jan Černý, Brandon A DaSilva, Tian Yi Zhang, Muthalagu Ramanathan et al. · 2024 · British Journal of Haematology
  93. The role of mutations in the cohesin complex in acute myeloid leukemia
    Claire Mazumdar, Ravindra Majeti · 2016 · International Journal of Hematology
  94. Clonal approaches to understanding the impact of mutations on hematologic disease development
    Jyoti Nangalia, Emily Mitchell, Anthony Richard Green · 2019 · Blood
  95. Experimental Modeling of Myeloproliferative Neoplasms
    Lucie Lanikova, Oľga Babošová, Josef T. Prchal · 2019 · Genes
  96. Clones assemble! The clonal complexity of blood during ontogeny and disease
    Miguel Ganuza, Trent Hall, Esther A. Obeng, Shannon McKinney‐Freeman · 2020 · Experimental Hematology
  97. Clonal hematopoiesis and vascular disease
    Kaushik V Amancherla, John A. Wells, Alexander G. Bick · 2022 · Seminars in Immunopathology
  98. Molecular Pathways in Clonal Hematopoiesis: From the Acquisition of Somatic Mutations to Transformation into Hematologic Neoplasm
    Charles Gaulin, Katalin Kelemen, Cecilia Arana Yi · 2022 · Life
  99. Genetic and environmental risks for clonal hematopoiesis and cancer
    Stephanie Franco, Lucy A. Godley · 2024 · The Journal of Experimental Medicine
  100. Comparative analysis of the Mexico City Prospective Study and the UK Biobank identifies ancestry-specific effects on clonal hematopoiesis
    Sean Wen, Pablo Antonio Kuri-Morales, Fengyuan Hu, Abhishek Nag, Ioanna Tachmazidou, Sri V. V. Deevi, Haeyam Taiy, Katherine R. Smith, Douglas P. Loesch, Oliver S. Burren et al. · 2025 · Nature Genetics